However, we found that Gal-3 levels in genetic AD and EOAD samples were significantly upregulated in both cortex and hippocampus compared to control cases, suggesting a similar Gal-3-associated immune response in both AD groups. The gene discussed is LGALS3; the disease is Alzheimer disease.